Filing Details

Accession Number:
0001209191-13-047614
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2013-10-07 15:26:49
Reporting Period:
2013-08-13
Filing Date:
2013-10-07
Accepted Time:
2013-10-07 15:26:49
Original Submission Date:
2013-08-15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229762 Cindy Jacobs 1522 217Th Place Se, Suite 100
Bothell WA 98021
Evp, Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-08-19 1,364 $8.68 25,780 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This amended Form 4 is filed to correct the transaction date, which was previously inadvertently reported as August 13, 2013.
  2. This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on August 19, 2013, which transaction was previously reported.
  3. This amended report is filed to correct the number of shares disposed of in connection with the sale of shares to satisfy the reporting person's tax liability in connection with the vesting of RSUs on August 13, 2013, which transaction was previously reported.